XML 45 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Stock Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Assumptions Used in Estimating the Fair Value of Options Granted The following assumptions were used in estimating the fair value of options granted during the period ended March 31, 2021:
 
   
March 31,
2021
  
March 31,
2020
 
Dividend yield
   0.00  0.00
Risk-free interest rate
   0.96  0.55
Expected volatility
   24.64  22.30
Weighted average expected life
   6.5   6.5 
Weighted average per share value of options
  $2.76  $1.84 
Summary of Stock Option Activity
A summary of the Company’s stock option activity for the period ended March 31, 2021 is presented below.
 
Stock Options
  
Shares
   
Weighted
Average
Exercise Price
   
Weighted
Average
Remaining in
Contractual
Term (Years)
   
Aggregate
Intrinsic
Value
 
Outstanding December 31, 2020
   218,115   $7.89    9.30    451,154 
Granted
(1)
   28,350    10.21    6.50    —   
Exercised
   —      —      —      —   
Forfeited
   —      —      —      —   
   
 
 
             
 
 
 
Outstanding March 31, 2021
   246,465    8.16    9.15    1,498,801 
   
 
 
             
 
 
 
Options exercisable at March 31, 2021
   11,923    7.88    9.00    75,804 
   
 
 
             
 
 
 
(1)   Includes 7,998 shares granted as a nonqualified stock option inducement award to the Company’s President and Chief Operating Officer
 
Summary of Nonvested Stock option Activity
The following table summarizes information about the Company’s nonvested stock option activity for the three months ended March 31, 2021:
 
Stock Options
  
Shares
   
Weighted Average
Grant Date Fair
Value
 
Nonvested at December 31, 2020
   218,115   $1.98 
Granted
   28,350    2.76 
Vested
   (11,923   1.83 
Forfeited
   —      —   
   
 
 
   
 
 
 
Nonvested at March 31, 2021
   234,542   $2.06 
   
 
 
   
 
 
 
           
Summary of Restricted Stock Unit Activity At March 31, 2021, the Company had $426,000 in estimated unrecognized compensation costs related to outstanding stock options that is expected to be recognized over a weighted average period of 4.21 years.
 
Restricted Stock
  
Shares
   
Weighted Average
Grant Date Fair
Value
 
Nonvested at December 31, 2020
   84,949   $7.87 
Granted
(1)
   11,436    10.21 
Vested
   (4,770   7.88 
Forfeited
   —      —   
   
 
 
   
 
 
 
Nonvested at March 31, 2021
   91,615   $8.16 
   
 
 
   
 
 
 
 
(1)
Includes 998 shares granted as a restricted stock inducement award to the Company’s President and Chief Operating Officer